Ameriprise’s Acorda Therapeutics ACOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-439
| Closed | -$27K | – | 3843 |
|
|
2020
Q3 | $27K | Buy |
+439
| New | +$33.1K | ﹤0.01% | 3695 |
|
|
2020
Q2 | – | Sell |
-1,924
| Closed | -$215K | – | 3753 |
|
|
2020
Q1 | $215K | Sell |
1,924
-1,697
| -47% | -$334K | ﹤0.01% | 3423 |
|
|
2019
Q4 | $886K | Buy |
3,621
+77
| +2% | +$19.4K | ﹤0.01% | 3109 |
|
|
2019
Q3 | $1.22M | Buy |
3,544
+995
| +39% | +$541K | ﹤0.01% | 2932 |
|
|
2019
Q2 | $2.35M | Buy |
2,549
+9
| +0.4% | +$11.1K | ﹤0.01% | 2650 |
|
|
2019
Q1 | $4.05M | Buy |
2,540
+103
| +4% | +$186K | ﹤0.01% | 2357 |
|
|
2018
Q4 | $4.56M | Buy |
2,437
+71
| +3% | +$155K | ﹤0.01% | 2175 |
|
|
2018
Q3 | $5.58M | Sell |
2,366
-462
| -16% | -$1.43M | ﹤0.01% | 2272 |
|
|
2018
Q2 | $9.74M | Buy |
2,828
+104
| +4% | +$318K | ﹤0.01% | 1761 |
|
|
2018
Q1 | $7.73M | Buy |
2,724
+227
| +9% | +$680K | ﹤0.01% | 1850 |
|
|
2017
Q4 | $6.43M | Sell |
2,497
-105
| -4% | -$298K | ﹤0.01% | 1948 |
|
|
2017
Q3 | $7.38M | Sell |
2,602
-325
| -11% | -$856K | ﹤0.01% | 1799 |
|
|
2017
Q2 | $6.92M | Buy |
2,927
+544
| +23% | +$1.08M | ﹤0.01% | 1837 |
|
|
2017
Q1 | $6.01M | Buy |
2,383
+84
| +4% | +$242K | ﹤0.01% | 1898 |
|
|
2016
Q4 | $5.19M | Buy |
2,299
+22
| +1% | +$52.3K | ﹤0.01% | 2022 |
|
|
2016
Q3 | $5.7M | Sell |
2,277
-858
| -27% | -$2.56M | ﹤0.01% | 1880 |
|
|
2016
Q2 | $9.6M | Buy |
3,135
+244
| +8% | +$794K | 0.01% | 1427 |
|
|
2016
Q1 | $9.18M | Buy |
2,891
+1,132
| +64% | +$4.7M | 0.01% | 1486 |
|
|
2015
Q4 | $9.03M | Sell |
1,759
-496
| -22% | -$2.17M | 0.01% | 1517 |
|
|
2015
Q3 | $7.17M | Buy |
2,255
+474
| +27% | +$1.84M | ﹤0.01% | 1715 |
|
|
2015
Q2 | $7.12M | Buy |
1,781
+54
| +3% | +$209K | ﹤0.01% | 1877 |
|
|
2015
Q1 | $6.9M | Buy |
1,727
+94
| +6% | +$431K | ﹤0.01% | 1877 |
|
|
2014
Q4 | $8.01M | Buy |
1,633
+1
| +0.1% | +$4.29K | ﹤0.01% | 1696 |
|
|
2014
Q3 | $6.64M | Sell |
1,632
-902
| -36% | -$3.38M | ﹤0.01% | 1818 |
|
|
2014
Q2 | $10.3M | Buy |
2,534
+1,090
| +75% | +$4.44M | 0.01% | 1515 |
|
|
2014
Q1 | $6.57M | Buy |
1,444
+27
| +2% | +$109K | ﹤0.01% | 1848 |
|
|
2013
Q4 | $4.96M | Sell |
1,417
-74
| -5% | -$289K | ﹤0.01% | 1999 |
|
|
2013
Q3 | $6.13M | Buy |
1,491
+44
| +3% | +$190K | ﹤0.01% | 1802 |
|
|
2013
Q2 | $5.73M | Buy |
+1,447
| New | +$5.96M | ﹤0.01% | 1806 |
|
Other funds holding ACOR
BCM
Ameriprise's ACOR Position: Q4 2020 in Review
Ameriprise sold out of Acorda Therapeutics (ACOR) in Q4 2020, closing a stake of 439 shares — an estimated $27K sold.
Ameriprise first reported a position in ACOR in Q2 2013 and held it in 29 quarters. The position peaked at $10.3M in Q2 2014. 47 funds tracked by Wall St. Rank hold ACOR as of Q4 2020.
- Ameriprise reported no remaining Acorda Therapeutics position as of Q4 2020 after selling out during the quarter.
- Ameriprise sold 439 Acorda Therapeutics shares in Q4 2020, an estimated $27K.
- Ameriprise first reported a position in Acorda Therapeutics in Q2 2013 and held it in 29 quarters.
- Ameriprise's Acorda Therapeutics position peaked at $10.3M in Q2 2014.
- 47 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q4 2020.
Based on Ameriprise's 13F filing for Q4 2020, filed 12 Feb 2021.